should bpc 157 be taken daily BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or bpc 157 daily dosage injection
Description
BPC-157 has a favorable safety profile, with no significant toxicity reported in clinical or preclinical studies

Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
For example if patient is suffering neuroppathy pain on leg below knee, injection sites on leg below knee are chosen for injection

This balanced approach can harness the benefits while minimizing uncertainties
Soft Tissue Therapy Soft tissue therapy can address the tightness and tension in the leg muscles, providing temporary relief from RLS
